Press Releases Applied BioCode Corporation

Equities

6598

KYG0488D1051

End-of-day quote Taiwan S.E. Other stock markets 18:00:00 2024-05-12 EDT			5-day change	1st Jan Change
19.9 ^TWD	-0.75%		-0.50%	-21.34%

04-15	Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	CI
03-21	Applied BioCode Announces CEO Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	04-15	BU
Applied BioCode Announces Retirement of CEO Chris Bernard	03-21	BU
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	23-09-28	BU
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	23-06-12	BU
Applied BioCode Announces Distribution Agreement with Medline Industries	23-05-08	BU
Applied BioCode Announces 2022 Q4 and Full year Revenue	23-02-27	BU
Applied BioCode : Announced the Appointment of Remuneration Committee Members resolved by the Board of Directors	22-06-22	PU
Applied BioCode : Announced the Company's Board Elected Chairperson	22-06-22	PU
Applied BioCode : The Company is Invited to Attend an Online Forum Held by CAPITAL SECURITIES CORP.	22-06-17	PU
Applied BioCode : Announced the Company's 2022 Shareholders' General Meeting resolved the Release of non-compete restriction for newly elected directors	22-06-13	PU
Applied BioCode : Announcement the Change of the Company's Audit Committee Members	22-06-13	PU
Applied BioCode : Important resolutions of the Company's 2022 Shareholders' General Meeting	22-06-13	PU
Applied BioCode : Announcement the Term Expired of Company's Remuneration Committee Members Due to the Election of Directors	22-06-13	PU
Applied BioCode : The Company's Election of directors at the Company's 2022 Shareholders' General Meeting	22-06-13	PU
Applied BioCode : Announcement on behalf of subsidiary, Applied BioCode, Inc., signed an amended license and supply agreement with IDEXX Technologies GmbH	22-05-27	PU
Applied BioCode : The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting (Location confirmed and electronic voting period amended)	22-04-28	PU
Applied BioCode : The Company is Invited to Attend an Online Forum Held by JihSun Securities	22-04-21	PU
Applied BioCode : At the request of TWSE, the Company announce related financial information	22-04-11	PU
Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer	22-03-24	BU
Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States	22-03-14	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Applied BioCode Corporation

Equities

6598

KYG0488D1051

Press Releases

Filters